FDA warnings as menopause UTIs turn fatal

A study shows that vaginal estrogen significantly reduces the risk of severe UTIs, sepsis, and death in menopausal women with recurrent infections. Despite longstanding medical recommendations, only about 10% of eligible women use the treatment, largely due to FDA warnings stemming from misinterpretations of past studies. Many women have suffered preventable health declines and deaths because healthcare providers failed to offer or prescribe this simple, cost-effective therapy.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل